M
Moleculin Biotech
MBRX
2.24000
USD
-0.85
(-27.51%)
مغلق
حجم التداول
540
الربح لكل سهم
0
العائد الربحي
0
P/E
-0
حجم السوق
7,225,099
الأخبار
العنوان: Moleculin Biotech
القطاع: Healthcare
الصناعة: Biotechnology
Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of highly resistant tumors and viruses. The company's lead program, Annamycin is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.